MedTrace Logo

Precision Medicine for Prediction & Prevention of Early Pre-eclampsia

NCT04412681 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2021-03-22

No results posted yet for this study

Summary

This study aims to evaluate the feasibility of implementing a clinical model for precision screening of early pre-eclampsia into the current prenatal screening service at Sunnybrook Health Sciences Center (SHSC).

Conditions

  • Pre-Eclampsia

Interventions

DIAGNOSTIC_TEST

Enhanced PE Screening

To better identify women at risk for pre-eclampsia during pregnancy.

Sponsors & Collaborators

  • North York General Hospital

    collaborator OTHER

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Ronzoni · Sunnybrook Health Sciences Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-06-01
Completion
2022-06-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04412681 on ClinicalTrials.gov